advertisement
Abstract #8542 Published in IGR 5-1
A clinical observation of human aqueous drainage implant for refractory glaucoma
Hailin M; Jinxia M; Hongliang ZChinese Ophthalmic Research 2002; 20: 543-545
OBJECTIVE: To observe the clinical results of a new aqueous drainage implant made in China, Human Aqueous Drainage implant (HAD), for refractory glaucoma. METHODS: HAD implantation were performed on 21 cases (21 eyes) with refractory glaucoma, including 15 males and six females. There were seven cases with neovascular glaucoma, three with iridocorneal endothelial syndrome, seven with aphakic glaucoma, one with juvenile glaucoma, and three failed filtering surgery. The average age was 46.76 ± 14.81 years. Mean preoperative introcular pressure (IOP) was 38.71 ± 11.38 mmHg. Postoperative mean follow-up time was 13.90 ± 8.99 months. RESULTS: After HAD implantation, average IOP was 12.71 ± 5.82 mmHg and its average lowering value was 26 mmHg. The surgical success rate was 80.95%. Complications after surgery included temporary hyphema (14.29%), anterior uveitis (14.29%), choroidal detachment (38.10%), conjunctival erosion and dislocation of the plate (4.76%), shallow anterior chamber (38.10%), complicated cataract (9.52%), and decompensation of the corneal endothelial (4.76%). CONCLUSIONS: HAD implantation is an effective method for refractory glaucoma. Its clinical results and postoperative complications are comparable to the imported implants.LA: Chinese
Dr. M. Hailin, Anyang Eye Hospital, Anyang 455000, China
Classification:
12.8.2 With tube implant or other drainage devices (Part of: 12 Surgical treatment > 12.8 Filtering surgery)
